Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
International Journal of Immunopathology and Pharmacology
|
April 19, 2011
The combination of immunosuppressive drugs with 8-methoxypsoralen and ultraviolet a light modulates the myeloid-derived dendritic cell function
A Failli, A Legitimo, A Mazzoni, et al.
Blood
|
November 1, 1985
T cell lineage involvement in lymphoid blast crisis of chronic myeloid leukemia
M Allouche, A Bourinbaiar, V Georgoulias, et al.
Clinical and Experimental Immunology
|
March 10, 2020
Vitamin D status and the immune assessment in 22q11.2 deletion syndrome
A Legitimo, V Bertini, G Costagliola, et al.
Blood
|
March 1, 1986
Abnormal in vitro differentiation of peripheral blood clonogenic B cells in common acute lymphoblastic leukemia during complete remission
R Consolini, J Bréard, A Bourinbaiar, et al.
Pathologica
|
January 1, 1983
[Complex chromosome translocation in a case of congenital monocytic leukemia]
P Simi, E Tarantino, P Macchia, et al.
Leukemia Research
|
August 1, 1997
The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia
R Consolini, A Legitimo, M Cattani, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 6, 2012
Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure
A Failli, R Consolini, A Legitimo, et al.
Seizure
|
May 8, 2018
Generalized epilepsy and mild intellectual disability associated with 13q34 deletion: A potential role for SOX1 and ARHGEF7
A Orsini, A Bonuccelli, P Striano, et al.
Epilepsy & Behavior Reports
|
March 7, 2020
Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome
A Orsini, G Costagliola, D Perna, et al.
Haematologica
|
September 1, 1993
Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias
R Consolini, F Scamardella, A Legitimo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
International Journal of Immunopathology and Pharmacology
|
April 19, 2011
The combination of immunosuppressive drugs with 8-methoxypsoralen and ultraviolet a light modulates the myeloid-derived dendritic cell function
A Failli, A Legitimo, A Mazzoni, et al.
Blood
|
November 1, 1985
T cell lineage involvement in lymphoid blast crisis of chronic myeloid leukemia
M Allouche, A Bourinbaiar, V Georgoulias, et al.
Clinical and Experimental Immunology
|
March 10, 2020
Vitamin D status and the immune assessment in 22q11.2 deletion syndrome
A Legitimo, V Bertini, G Costagliola, et al.
Blood
|
March 1, 1986
Abnormal in vitro differentiation of peripheral blood clonogenic B cells in common acute lymphoblastic leukemia during complete remission
R Consolini, J Bréard, A Bourinbaiar, et al.
Pathologica
|
January 1, 1983
[Complex chromosome translocation in a case of congenital monocytic leukemia]
P Simi, E Tarantino, P Macchia, et al.
Leukemia Research
|
August 1, 1997
The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia
R Consolini, A Legitimo, M Cattani, et al.
Journal of Biological Regulators and Homeostatic Agents
|
January 6, 2012
Evaluation of in vitro cytotoxicity of oxaliplatin and 5-fluorouracil in human colon cancer cell lines: combination versus sequential exposure
A Failli, R Consolini, A Legitimo, et al.
Seizure
|
May 8, 2018
Generalized epilepsy and mild intellectual disability associated with 13q34 deletion: A potential role for SOX1 and ARHGEF7
A Orsini, A Bonuccelli, P Striano, et al.
Epilepsy & Behavior Reports
|
March 7, 2020
Efficacy and tolerability of mycophenolate mofetil in a pediatric Rasmussen syndrome
A Orsini, G Costagliola, D Perna, et al.
Haematologica
|
September 1, 1993
Evaluation of minimal residual disease in high risk childhood acute lymphoblastic leukemia using an immunological approach during complete remission. AIEOP Cooperative Group for Immunology of Acute Leukemias
R Consolini, F Scamardella, A Legitimo, et al.
Page
of 5